Pancreatic Cancer Research

ResearcherTongji UniversityActive in the last 2 years

Ming Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3996-4304; OpenAlex author ID A5012806956. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 3

  1. ZBTB7A interferes with the RPL5-P53 feedback loop and reduces endoplasmic reticulum stress-induced apoptosis of pancreatic cancer cells. Last author DOI 10.1002/mc.23772↗
  2. LINC00941 promotes glycolysis in pancreatic cancer by modulating the Hippo pathway. Co-author DOI 10.1016/j.omtn.2021.07.004↗
  3. Upregulation of DLC-1 inhibits pancreatic cancer progression: Studies with clinical samples and a pancreatic cancer model. Last author DOI 10.3892/ol.2019.10871↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jie Tang · 1 shared paper, 2024 · strength 0.23
  2. Bo Chen · 1 shared paper, 2019 · strength 0.16
  3. Ran Cui · 1 shared paper, 2021 · strength 0.13
  4. Yongkun Wang · 1 shared paper, 2021 · strength 0.13
  5. Bo Chen · 1 shared paper, 2021 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.